To test whether HCaRG might act as a tumor-suppressor gene, we initially evaluated the impact of its overexpression in a mouse renal adenocarcinoma cell line, Renca cells and a melanoma cell line, B16-F10 cells. Here, COMMD5 is linked to papillary renal cell carcinoma.